School of Medicine
Showing 1-100 of 137 Results
-
Jason Andrews
Associate Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsOur laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.
-
Florian Bach
Postdoctoral Scholar, Infectious Diseases
BioI'm a molecular infection biologist by training, but shifted my focus from pathogens to hosts for my graduate research. During my PhD with Phil Spence in Edinburgh I studied both falciparum and vivax malaria using controlled human (re)infection models, collaborating closely with the groups of Simon Draper and Angela Minassian in Oxford. As a hybrid bioinformatician and experimentalist, I love systems immunology for answering complex questions about human health. For my postdoc, I study in how the human immune response to malaria evolves in infants as they become reinfected and age. I'm also interested in how such early-life immunological events, malaria and beyond, may affect vaccine responses and immune development later in life. I address this question by making use of a longitudinal study cohort of infants receiving monthly chemoprevention in Eastern Uganda, together with our collaborators at UC San Francisco and IDRC Uganda.
-
Niaz Banaei
Professor of Pathology and of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsHis research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.
-
Brian Blackburn
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsMy interests include parasitology and global health; I've investigated cryptosporidium and angiostrongylus outbreaks; schistosoma/strongyloides seroprevalence in refugees, and the distribution and impact of ITNs for malaria and filariasis prevention in Nigeria and India. I have done clinical and programmatic work at teaching hospitals in Liberia and Bangladesh and have opportunities for research in Bangladesh and Kenya, in collaboration with ICDDR,B and CDC, Kenya
-
Catherine Blish
George E. and Lucy Becker Professor in Medicine
Current Research and Scholarly InterestsThe major goal of our research is to gain insight into the prevention and control of HIV and other viral pathogens by studying the interplay between the virus and the host immune response. We investigate the role of various arms of the immune response, but with a particular focus on NK cells. We hope to gain additional insights into control of infectious diseases by studying how pregnancy modulates immune responses.
-
Paul Bollyky
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsWe seek to understand how interactions between bacteria, bacteriophages, and the human immune system impact our health and disease. Our goals are to gain insights into the pathogenesis of bacterial infections and to generate novel therapies to improve human health.
-
Hector Fabio Bonilla
Clinical Associate Professor, Medicine - Infectious Diseases
BioAs a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
-
Joseph David Cooper
Clinical Assistant Professor (Affiliated), Medicine - Med/Infectious Diseases
BioJoseph David Cooper attended Bucknell University for his undergraduate degree with a dual major in Biology and Philosophy. He graduated from St. George’s University School of Medicine and went on to complete his Internal Medicine residency at Geisinger Medical Center in Danville, Pennsylvania. He remained at Geisinger for an additional year as Chief Resident in Internal Medicine with a focus on teaching and the education of trainees. He completed his Infectious Diseases fellowship at Montefiore Medical Center-Albert Einstein College of Medicine in the Bronx, New York. He is board certified in both Internal Medicine and Infectious Disease.
He began working at Santa Clara Valley Medical Center primarily in the PACE (Partners in AIDS Care and Education) and Infectious Diseases Clinics in July 2019. He has an active outreach HIV clinic at Valley Health Center in Gilroy, California once a month. He sees outpatients with general infectious diseases and provides inpatient consultation at Santa Clara Valley Medical Center. He is actively involved in the teaching and training of Stanford University Infectious Diseases fellows and medical students, including Internal Medicine residents from his home institution and Kaiser Permanente Santa Clara. Dr. Cooper holds an appointment of Clinical Assistant Professor (Affiliated) at Stanford University School of Medicine as of September 2020. He is the acting Associate Medical Director of the PACE Clinic as of March 2021.
Dr. Cooper is an active member of the American College of Physicians, Infectious Diseases Society of America, and the HIV Medicine Association. He volunteers his time within these professional organizations previously serving on workgroups surrounding education, mentoring of trainees and as an ad hoc reviewer for infectious diseases and general internal medicine journals. His professional interests include HIV/AIDS, Hepatitis C, HIV PrEP/PEP, sexually transmitted infections, emerging infectious diseases, the intersection of substance use with infectious diseases and physician/clinician wellness. Dr. Cooper is passionate about providing high quality, evidence-based care to people living with HIV and AIDS. He uses his professional expertise, passion and energy to ensure that his patients remain as well and healthy as possible.
Outside of medicine and work, you can find Dr. Cooper spending time with his wife and two daughters - hiking and exploring the Bay Area and beyond, listening to music, gardening, exercising and playing sports. -
Sudeb C. Dalai
Adjunct Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Sudeb Dalai, MD PhD is an Infectious Disease Physician at Stanford University School of Medicine and the Palo Alto Medical Foundation. Currently a Clinical Assistant Professor (Teaching) at Stanford, he has taught courses and conducted research in academia/industry for over 18 years.
Dr. Dalai completed his undergraduate degree at MIT, MD and MS at Stanford, PhD in Epidemiology at UC Berkeley School of Public Health, Internal Medicine Residency at UCSD, and Fellowship in Infectious Diseases at Stanford. He has received numerous teaching and leadership awards and research grants and has co-authored multiple peer-reviewed publications. His work has been supported by the Infectious Diseases Society of America, the Howard Hughes Medical Institute, the Paul and Daisy Soros Foundation, and the National Institutes of Health. Dr. Dalai is an internationally-invited speaker and has been featured in multiple media outlets including ABC, NBC, Good Morning America, US News & World Report, Buzzfeed, and The Huffington Post. In 2003 he was elected to the MIT Board of Trustees and in 2020 he was voted as a Board Member of the MIT Club of Northern California. -
Stanley Deresinski
Clinical Professor, Medicine - Infectious Diseases
BioDr. Deresinski received his medical degree from the University of Illinois College of Medicine and received training in Internal Medicine there and at Stanford, where he also completed a fellowship in Infectious Diseases. For 3 decades, he maintained a private practice in Infectious Disease, HIV, and Travel Medicine and was Hospital Epidemiologist at Sequoia Hospital where he also served as President of the Medical Staff for 2 years. He was also Associate Chief of the Division of Infectious Diseases and for 14 years was Director of the AIDS Program at the Santa Valley Medical Center, a Stanford-affiliated public teaching hospital. During that time he won several teaching awards at Stanford. In 1987, he founded the AIDS Community Research Consortium, serving as its Medical Director and Chairman of the Board for almost 2 decades. He was also Site Principal Investigator for the Stanford ACTU and the California Collaborative Treatment Group and has worked on AIDS education in Kampala, Uganda. Dr. Deresinski is currently Clinical Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine at Stanford and is Medical Director of the Stanford Antimicrobial Stewardship Program and Chair of the Pharmacy and Therapeutics Committee and of the Specialty Drugs Subcommittee. He has special interests in antimicrobial resistance, optimal antimicrobial use, fungal infections, and infections in immunocomopromised hosts.
Dr. Deresinski has published more than 100 peer-reviewed papers as well as number of book chapters. He is a Section Editor of Clinical Infectious Diseases and is a past Chair of the Infectious Diseases Society of America (IDSA) Standards and Practice Guidelines Committee as well as member of the IDSA Board of Directors. He is a member of the HIVMA, in addition to a number of other societies including SHEA and is a Fellow in the American College of Physicians as well as IDSA. He is a past winner of the IDSA Watanakunokorn Clinician of the YearAward. -
Thomas Duane Dieringer
Clinical Assistant Professor, Medicine - Infectious Diseases
BioI have worked over the last 10 years to build a foundation for a career in academic infectious diseases by providing thoughtful dedicated care for my patients, conducting clinically focused research, and remaining an engaged educator for developing physicians. My passion for the study of infectious diseases has led me to complete a general infectious diseases fellowship and additional focused training in transplant and immunocompromised infectious diseases. I will continue to work diligently with my colleagues focusing on the growth of medical learners, advancing patient centered clinical research, and striving to provide the highest quality of care to patients.
-
Shirit Einav
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsOur basic research program focuses on understanding the roles of virus-host interactions in viral infection and disease pathogenesis via molecular and systems virology single cell approaches. This program is combined with translational efforts to apply this knowledge for the development of broad-spectrum host-centered antiviral approaches to combat emerging viral infections, including dengue, coronaviruses, encephalitic alphaviruses, and Ebola, and means to predict progression to severe disease.
-
Jessica Ferguson
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Ferguson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have undergone bone marrow or solid organ transplantation and patients with hematologic or solid malignancies on chemotherapy.
-
Jenna Forsyth
Academic Program Professional, Medicine - Med/Infectious Diseases
BioJenna is a postdoctoral fellow with the Woods Institute for the Environment. She completed her PhD with the Emmett Interdisciplinary Program in Environment and Resources and obtained her Master's in Civil and Environmental Engineering from the University of Washington. Her research brings together principles of environmental science, epidemiology, and behavior change. She hopes to develop and evaluate interventions to minimize exposures to contaminants and disease vectors in low-income countries. Her most recent research on lead contamination in food has brought her to Bangladesh.
-
Philip Grant
Assistant Professor of Medicine (Infectious Diseases)
BioMy research focuses on antiretroviral therapy and complications of HIV including immune reconstitution inflammatory disease, osteoporosis, and cardiovascular disease.
-
Jessica Grembi
Postdoctoral Scholar, Infectious Diseases
BioEnvironmental enteric dysfunction (EED) affects 50-90% of children in low-income countries and is likely an important factor in child stunting as it impedes efficient nutrient uptake in the small intestine. EED is suspected to be the result of persistent exposure to enteric pathogens, although it has not been correlated with any specific pathogen. My research explores the interplay of gut microbiota, including enteric pathogens, and the host immune system with a focus on understanding EED so we can rationally design treatments and preventive measures.
-
Dora Ho
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsDr. Ho did her PhD work in HSV pathogenesis and postdoctoral research in CNS gene therapy with viral vectors. She is currently the clinical chief of the Division of Infectious Diseases and Geographic Medicine. She specializes in infection complications of immunocompromised patients, such as those with cancers, solid organ transplant or bone marrow transplant.
-
Seth Ari Sim-Son Hoffman
Postdoctoral Medical Fellow, Infectious Diseases
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2021
Fellow in MedicineCurrent Research and Scholarly InterestsClinical research to benefit underserved populations.
-
Mark Holodniy
Professor of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsMy research program is currently focused in three areas: 1) Translational research (viral evolution and antiviral resistance prevalence and development), 2) Clinical trials (diagnostic assay/medical device, antimicrobials and immunomodulators), and 3) Health services research focusing on public health, infectious diseases and clinical outcomes.
-
Marisa Holubar
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Marisa Holubar specializes in the treatment of infectious diseases and works primarily in the inpatient setting. She is particularly interested in antimicrobial stewardship.
-
Prasanna Jagannathan
Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
BioI am an Infectious Diseases specialist with a research program in human immunology focused on malaria-specific immune responses in pregnancy and infancy. My current research program is to further our understanding of the mechanisms of clinical immunity to malaria through field-based studies, and to better understand the immunologic consequences of malaria control interventions.
Given the profound global impact of the COVID-19 pandemic, we are also testing novel immune modulating therapeutics for the treatment of SARS-CoV-2 infected patients with mild infection (NCT 04331899). In this study 120 SARS-CoV-2 infected patients (both symptomatic and asymptomatic) are being randomized to receive Lambda vs. placebo to test the hypothesis that SARS-CoV-2-infected individuals given Lambda at the time of diagnosis have a shortened duration of viral shedding in comparison to patients given placebo. I serve as as the co-PI of this study along with Dr. Upi Singh at Stanford. -
Shanthi Kappagoda
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsCompleted a Masters degree in Health Services Research in 2012. Research focused on using network models to develop a clinical research agenda for neglected tropical diseases.
-
Abraar Karan, MD MPH DTM&H
Postdoctoral Medical Fellow, Infectious Diseases
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2022
Fellow in MedicineBioI am an infectious disease fellow and post-doctoral researcher in the Division of Infectious Diseases and Geographic Medicine, the Luby Lab, the Center for Innovation in Global Health, and the Woods Institute for the Environment with interests in emerging infections, infectious disease epidemiology, and global health equity. I am currently the Principal Investigator of a randomized controlled trial investigating whether air filtration and ventilation can reduce spread of Covid19 in homes.
_______
From February to October 2020, I worked on COVID19 response for the state of Massachusetts as a medical fellow to the state health commissioner. From November to January 2021, I worked as a research consultant to the WHO commissioned Independent Panel for Pandemic Preparedness and Response on Covid-19 epidemiology. I also served as a research assistant for the Harvard College Fall course on Covid-19 and epidemics. Furthermore, I was involved in Biden-Harris campaign's Covid-19 policy writing for school reopenings. In 2018, I co-founded Longsleeve insect repellent, winner of the 2018 Harvard Business School New Venture Competition and a finalist in the 2019 Harvard President's Challenge. In summer and fall of 2022, I worked on the Monkeypox outbreak response for Los Angeles County. I have peer-reviewed for the CDC's EID Journal; Clinical Infectious Diseases; Lancet Infectious Diseases, and JAMA.
My previous work over the past 14 years has included various projects in Latin America (Mexico, Honduras, Nicaragua, Haiti, Dominican Republic), Asia (India, Thailand), and Sub-Saharan Africa (Rwanda, Uganda, Mozambique). In 2011-2012, as a Yale Parker Huang Fellow, I conducted an anthropological research study in India exploring sex trafficking and intergenerational sex work in Hyderabad and Delhi. I am also interested in the intersection between medical ethics and global health (particularly neocolonialism). I participated as a medical fellow in Auschwitz studying the history of the Holocaust for the FASPE program in 2016; and led the AMA Journal of Ethics twice (2016-17 on international healthcare systems; 2019-20 on pandemic response).
Since January 2019, I have also been a columnist at the British Medical Journal. Prior to that, I co-edited the book, "Protecting the Health of the Poor", which was published in December 2015. I have authored works in the NEJM, The Lancet, The BMJ, Academic Medicine, Health Affairs, NPR, WaPo, Vox, Los Angeles Times, CNN, Scientific American, Huffpost, Boston Globe, Harvard Business Review, and other major publications. Press coverage has included: NBC, ABC, BBC, PBS, CBS, CNN, MSNBC, Washington Post, New York Times, SF Chronicle, Bloomberg, Boston Globe, ProPublica, WSJ, TIME, TMZ, Science Friday, Medium, The Verge, Politico, CBC News, MTV News, Democracy Now, NPR, ESPN, The Atlantic, The Hill, Business Insider, Vice, Mother Jones, Boston Magazine, Vox, Healthline, Forbes, Slate, STAT News, Harvard Public Health Magazine (cover story Spring 2020). For a full list of publications, please see "Publications" tab. For full list of media work, please see "Media" link. -
Melanie Ann Kiener
Postdoctoral Medical Fellow, Infectious Diseases
Fellow in MedicineBioI am an adult infectious disease fellow completing my post-doctoral research years in Dr. Desiree LaBeaud's lab. My research interests include global health epidemiology, infectious diseases diagnostics and global antimicrobial stewardship.
-
Minyoung Kevin Kim
Postdoctoral Scholar, Infectious Diseases
BioPostdoctoral researcher, School of Medicine, Stanford University - CA, USA
M.D., College of Medicine, Yonsei University - Seoul, South Korea
Ph.D., Chemistry and Material Science, Princeton University - NJ, USA
B.S., Chemistry, Yonsei University - Seoul, South Korea -
Michael Kozal
Senior Associate Dean for Veterans Affairs and Professor of Medicine (Infectious Diseases)
BioDr. Kozal was appointed Senior Associate Dean for Veteran Affairs at Stanford School of Medicine and Chief of Staff at VA Palo Alto Health Care System in 2021. Prior to coming to Stanford, he served as Associate Dean for Veteran Affairs at Yale University School of Medicine and the Chief of Staff at VA Connecticut Healthcare System.
Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal previously directed the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >40 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and is a current a member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents. -
Vivian Levy
Clinical Associate Professor (Affiliated), Medicine - Med/Infectious Diseases
Staff, Medicine - Med/Infectious DiseasesBioVivian Levy is Chief of Infectious Diseases at San Mateo Medical Center (SMMC), San Mateo County’s safety net hospital and clinic system in northern California since 2015 and the County’s STD Control Officer since 2006. San Mateo County has 760,000 persons and connects the urban centers of San Francisco and San Jose, California.
Dr. Levy leads Stanford’s Internal Medicine outpatient Infectious Diseases rotation for Internal Medicine residents. She has served 2 terms as president of the California STD/HIV Controllers Association. From 2004-2008, she was the medical officer for the Chemoprophylaxis for HIV prevention in men study in Lima, Peru.
In 2020, she was the San Mateo Medical Center site investigator for the Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 Infection. She began SMMC patient recruitment for Stanford outpatient COVID studies July 2020 with the goal of increasing historically underrepresented populations participation and access in COVID outpatient treatment trials.
She has an undergraduate degree from Brown University (1989,) an MD from Rush University Medical College in Chicago (1994,) completed internship in Internal Medicine at Cook County Hospital in Chicago (1995) Internal Medicine residency at Northwestern University (1997) and an Infectious Diseases and Geographic Medicine fellowship at Stanford University (2000-2004.) -
Anne Liu
Clinical Associate Professor, Pediatrics - Immunology and Allergy
Clinical Associate Professor, Medicine - Infectious Diseases
Clinical Associate Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care MedicineBioDr. Liu is a board-certified, fellowship-trained specialist in allergy/immunology and infectious disease. She is also a clinical associate professor in the Department of Medicine, Division of Infectious Diseases and the Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology at Stanford University School of Medicine.
Dr. Liu treats infections in patients with compromised immune systems, whether due to a primary immune deficiency or a condition like cancer or organ transplant. She helps patients to develop tolerance to medications they are allergic to so that they can receive the best, and sometimes the only, treatments available to them. She also treats allergies to antibiotics, aspirin, NSAIDs, chemotherapy, and more. She sees patients both long term and for urgent referrals, such as in cases of perioperative anaphylaxis. Dr. Liu also helps pediatric patients manage drug and food allergies.
One of Dr. Liu’s areas of focus is helping patients with allergies to antibiotics determine when they have lost an allergy, what antibiotics they can tolerate, and when to induce tolerance to an antibiotic. This not only can benefit the patient, but also have a positive public health impact, as labeling patients with a penicillin allergy may negatively affect their care and increase use
of broad-spectrum antibiotics.
She collaborates closely with colleagues from other disciplines, including pulmonology, otolaryngology, oncology, cardiology, dermatology, anesthesiology, and surgery. Her key objective in working with referring physicians is to help them safely deliver the best care for their patients.
For patients and families, Dr. Liu strives to help them navigate their care journey with as much ease and dignity as possible during what may be the most challenging time of their life. Her goal is to offer patients options, even when it may appear that they have no options left.
Dr. Liu’s research interests include optimizing care of patients with antibiotic allergies, including through use of decision support tools.
Dr. Liu has authored articles in the New England Journal of Medicine, Journal of Immunology, Journal of Allergy and Clinical Immunology in Practice, Clinical and Experimental Allergy, Mucosal Immunology, Diagnostic Microbiology and Infectious Disease, Science, and other publications. Dr. Liu authored the book chapter “Hypersensitivity Reactions to Monoclonal Antibodies” in Drug Allergy Testing.
Dr. Liu is certified in infectious disease by the American Board of Internal Medicine and in allergy and immunology by the American Board of Allergy and Immunology. She is also a member of the American College of Physicians, Infectious Diseases Society of America, and American Academy of Allergy, Asthma, and Immunology.
She has given presentations on antibiotic allergies, drug desensitization, and aspirin-exacerbated respiratory disease, among other topics. Dr. Liu’s honors include recognition from the American Academy of Asthma, Allergy, and Immunology, the American Medical Women’s Association, and the National Institutes of Health. -
Stephen Luby
Professor of Medicine (Infectious Diseases) and Senior Fellow at the Woods Institute and the Freeman Spogli Institute and Professor, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting pathways of infectious disease transmission in low income countries.
-
Moogdho Mim Mahzab
Postdoctoral Scholar, Infectious Diseases
BioMoogdho is a postdoctoral scholar at the Woods Institute for the Environment. He is a development economist, concentrating on political economy, environment and public health. He received his Ph.D. in Economics from the University of Virginia (UVa) in 2021. His research at UVa focused on how dishonest politicians (tax-evaders) affect public goods provision and public health in constituencies the politicians represent. At Stanford, he is working at the Luby Lab on improving Brick Kilns operations in South Asia to reduce air pollution and facilitate better public health.
-
Natalia Medvedeva
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr Natalia Medvedeva specializes in the treatment of infectious diseases. She has a special interest in antimicrobial stewardship and medical education.
-
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
-
Joanna Nelson
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.
-
Andrew Nevins
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsClinical general infectious diseases. Medical education.
-
Julie Parsonnet
George DeForest Barnett Professor of Medicine and Professor of Epidemiology and Population Health
Current Research and Scholarly InterestsI am an infectious diseases epidemiologist who has done large field studies in both the US and developing countries. We research the long-term consequences of chronic interactions between the human host and the microbial world. My lab has done fundamental work establishing the role of H. pylori in causing disease and understanding its epidemiology. Currently, our research dissects how and when children first encounter microbes and the long term effects of these exposures on health.
-
Ruoxi Pi
Postdoctoral Scholar, Infectious Diseases
BioI received my BS in Biological Sciences in Zhejiang University in China, where I conducted research in polyphasic taxonomy in anaerobic bacteria. I received my PhD in Yale University, where I studied the early events of retrovirus infection in animal models. Now in the Blish lab, I am investigating NK cell responses during HIV-1 infection and trying to manipulate the NK cells to target latently infected cells.
-
Benjamin Pinsky
Professor of Pathology, of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases)
Current Research and Scholarly InterestsDevelopment and application of molecular assays for the diagnosis and management of infectious diseases.
-
Kathleen Dantzler Press
Postdoctoral Scholar, Infectious Diseases
BioThroughout my scientific training, I have focused on building an interdisciplinary background in molecular parasitology, biochemistry, immunology, and public health to provide me with the skills needed to pursue development of a successful malaria vaccine. My PhD research at Harvard centered on understanding immune responses to the developing transmission stages of malaria. By providing the first evidence for natural immunity to immature transmission stages, this work supports interrupting development and maturation of these parasites as a novel approach to transmission-blocking vaccine design. During my postdoctoral fellowship and in the future, I hope to continue researching host-pathogen interactions with applications to malaria vaccine development, while also being involved in global health work in the field. Currently my work focuses on understanding mechanisms of natural immunity to malaria and immune tolerance, particularly in the context of gamma delta T cell and monocyte responses.
-
Orlando Quintero, MD
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Orlando Quintero is a board-certified, fellowship trained internist specializing in the diagnosis and treatment of infectious diseases. He is also clinical assistant professor in the Department of Medicine, Division of Infectious Diseases, at Stanford University School of Medicine.
As a clinician, Dr. Quintero diagnoses and treats infectious diseases in immunocompromised patients. This includes the prevention, diagnosis and treatment of infections in patients who are immunosuppressed because of Solid Organ Transplantation, Bone Marrow (Hematopoeitic Cell) Transplants, Hematologic Malignancies, Chemotherapy for Solid Tumors, HIV who receive Chemotherapy, Solid Organ or Bone Marrow Transplants Immunomodulators for Auto-Immune Diseases and other forms of immunodeficiency.
Dr. Quintero has published on topics including coronavirus in kidney transplant patients, prevention of cytomegalovirus in heart transplant patients, and prevention of urinary tract infections in renal transplant patients. His work has appeared in publications including Transplant Infectious Disease, Emerging Infectious Diseases, and the Journal of Heart and Lung Transplantation.
He has delivered presentations at meetings of organizations including the International Society for Heart and Lung Transplantation, Interscience Conference on Antimicrobial Agents and Chemotherapy, and American Society of Tropical Medicine and Hygiene. Topics of his presentations have included prevention of cytomegalovirus, prevention of recurrent urinary tract infections, Chagas disease in New York City, and more.
Currently, Dr. Quintero is conducting research on treatment of patients with COVID-19, prevention and treatment of invasive fungal infections of the gastrointestinal tract in immunocompromised patients, and the epidemiology of invasive fungal infections in heart transplant recipients.
Among his awards, He has received honors for his teaching and research from Albert Einstein College. He also has earned recognition from the Fred Hutchinson Cancer Research Center and the American Society of Transplantation.
Dr. Quintero’s volunteer community service includes participation in health fairs to promote HIV testing and hypertension control, plus disease management in the Garifuna population in New York – descendants of an Afro-indigenous population from the Caribbean island of St. Vincent.
He is a member of the Infectious Disease Society of American, Infectious Diseases Association of California, American Society of Transplantation, and HIV Medicine Association. -
David A. Relman
Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.
-
Cybele A. Renault, MD, DTM&H
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Renault has devoted her career to caring for vulnerable patient populations, both domestically and overseas. She completed her medical school and residency training at the University of Chicago, caring for underserved patients on Chicago's South Side, followed by a Chief Resident year at John H. Stroger, Jr. Hospital of Cook County, the public hospital serving the uninsured in Chicago. She began her career in global health as an Infectious Diseases fellow at Stanford, validating low-cost HIV diagnostics in Burkina Faso, and providing clinical service and teaching in India and Zimbabwe as a fellow, and later in Thailand, Uganda, Rwanda and Kenya as one of our Infectious Diseases faculty. Her clinical work is currently focused on caring for our Veteran population, working to empower Veterans to engage in their care, often in the setting of significant mental illness.
Dr. Renault is most passionate about medical education and program development to combat global antimicrobial resistance through antimicrobial stewardship, to create opportunities for the Internal Medicine residents centering on caring for vulnerable patient populations, and to develop impactful and sustainable programs in collaboration with our low- and middle-income partners for our Center for Innovation in Global Health. She served as Associate Program Director for the Internal Medicine Residency Program for 4 years prior to transitioning to her current role as Program Lead for Global Health, for which she leads the Global Health Track for the Internal Medicine residency program and develops global health initiatives for the Department of Medicine. She co-founded and has been director of the Stanford 2-week intensive global health course since its inception in 2012, she has structured trainee and faculty rotations based on evolving needs of our partner sites in Uganda, Rwanda and Zimbabwe, she is the primary contact for the ID/antimicrobial stewardship partnership between Stanford and Moi Teaching and Referral Hospital in Eldoret, Kenya, and she is leading Stanford's multi-disciplinary efforts to support our newest partner in Negele Arsi, Ethiopia.
Dr. Renault strives to augment Stanford's contributions and support for underserved patient populations in the United States. She established resident rotations in Shiprock, New Mexico and Chinle, Arizona through the Indian Health Service, and she is Faculty Advisor for the Internal Medicine Health Equity, Advocacy and Research concentration in the residency program. She also aspires to improve resources for women physicians. In 2016, Dr. Renault established the GME Women in Medicine Leadership Council, with the intention of creating community and encouraging conversations about professional and personal life decisions as women in the field of medicine. She is passionate about mentoring through sharing personal experiences, creating an environment that encourages reflection, and building skills to address challenges unique to women in medicine.
In 2022, in recognition of her passion for medical education and her success in program development, Dr. Renault was asked to join the leadership at Palo Alto Veterans Health Care System as Deputy Associate Chief of Staff for Education. In this role, she works with rotation directors to optimize their respective rotations to offer robust educational opportunities for trainees across specialties who are rotating at the Palo Alto VA. -
Izabela Mauricio Rezende
Postdoctoral Scholar, Infectious Diseases
BioI have a B.S. in Biology, M.Sc. in Immunology and Infectious diseases, Ph.D. in Microbiology, and a broad background in virology/microbiology and molecular biology applied to viral infectious diseases. I have a vast knowledge of classical virology, molecular biology, phylogenetic analysis, serological, and molecular diagnosis. I am working on recent YF outbreaks, focusing on viral dynamics, ecology, diagnosis, and the investigation of virological, immunological, and clinical aspects during the course of infection. We have supported the hospital and Secretary of Health of Minas Gerais with some laboratory testing applied to diagnosis of YF, viral genotyping related to YF patients suspected to have adverse events following vaccination, and other analysis. We also have been working on dynamics of the outbreak, on the virological, epidemiological, and immunological aspects during the course of yellow fever. During the COVID-19 pandemic, we also supported the Brazilian Ministry of Health with the SARS-CoV-2 diagnosis in human samples and also in the investigation of the SARS-CoV-2 RNA in surfaces of density public areas of Belo Horizonte. Since Nov/2018 I had been an editor in the journal Docência do Ensino Superior (RDES / GIZ / UFMG) and in Jan/2020 I became Editor-in-Chief.